Mahendra Bhati

Neuropsychiatrist

Bio:   Dr. Bhati is a board certified neuropsychiatrist with expertise in psychiatric diagnosis, psychopharmacology, and neuromodulation. He completed postdoctoral research studying transcranial magnetic stimulation (TMS) evoked potentials in schizophrenia and was a principle investigator for the DSM-5 academic field trials. His research experience included roles as an investigator in the first controlled clinical trials of deep brain stimulation and low field synchronized TMS for treatment of depression. His current interests include studying TMS-evoked potentials as biomarkers for neuropsychiatric disorders, augmented-reality TMS, closed-loop responsive neurostimulation for treatment of impulse and fear-related disorders, and magnetic resonance guided focused ultrasound for treatment-resistant obsessive compulsive disorder and depression.

Professional Education

  • Postdoctoral research, University of Pennyslvania, Neuropsychiatry (2007)
  • Residency, University of Pennsylvania, Psychiatry (research track) (2005)
  • Medical Education: Louisiana State University Health Sciences Center Registrar (2001) LA
  • B.S., Emory University, Biology (1996)
  • B.A., Emory University, Chemistry (1996)

Honors & Awards

  • Clinical Research Scholar, National Institutes of Health (2002-2005)
  • Earl Bond Award, University of Pennsylvania Department of Psychiatry (2013)
  • Health Care Hero, University of Pennsylvania Health System (2014)
  • Irma Bland Award for Excellence in Teaching Residents, American Psychiatric Association (2012)
  • Junior Investigator Grant Award, University of Pennsylvania (2007)
  • Ruth L. Kirschstein National Research Service Award, National Institutes of Health (2005-2007)
  • Small Grant Program Award, Stanford University Department of Psychiatry (2018)
  • Stunkard Faculty Award, University of Pennsylvania Department of Psychiatry (2010)
  • Travel Fellowship Award, Society of Biological Psychiatry (2006)

Administrative Appointments

  • Chief of Interventional Neuropsychiatry, Stanford University (2016 - Present)
  • Director of Electroconvulsive Therapy, Stanford University Hospital (2016 - Present)

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.